Skip to main content
. 2024 Apr 29;11(5):138. doi: 10.3390/jcdd11050138

Table 2.

Clinical, laboratory, and imaging features of patients affected by infective endocarditis, further subdivided on the basis of the secondary endpoint.

Whole Population (102) Secondary Endpoint
Clinical Features No Death (84) Death (18) p
Age 66 ±14 64.6 ±15 73.3 ±9 <0.01
Male gender 72 71% 60 71.4% 12 66.7% 0.7
Diabetes 14 13.7% 13 15.5 1 5.6% 0.3
CKD 30 29.4% 22 26.2% 8 44.4% 0.1
Embolic events 39 38.2% 30 35.7% 9 50% 0.3
Injective drug addiction 14 13.7% 13 15.5% 1 5.6 0.5
Atrial fibrillation 22 21.6% 17 20.2% 5 27.8% 0.5
IT 7 6.9% 6 7.1% 1 5.6% 0.9
IE-aHF 33 32.4% 22 26.2% 11 61.1% <0.01
IE on prosthesis 51 50% 39 46.4% 12 66.7% 0.1
Days S-D 20 (7–50) 21 7–60 7 5–20 0.07
Laboratory data
WBCC admission (×103/µL) 14 (9–28) 13.9 8.5–18 14 9–17 0.8
CRP admission (mg/dL) 4 (1.5–9.7) 3.8 1.4–7.6 8 3.9–16 0.02
PCT admission (µg/L) 0.13 (0–0.78) 0.1 0–0.5 0.6 0.0–3.6 0.3
WBCC peak (×103/µL) 19 (14–62) 19 15–24 19 14–25 0.5
CRP peak (mg/dL) 10.6 (4.2–17.5) 10.6 1.8–17 13.1 3.9–18.9 0.7
PCT peak (µg/L) 0.60 (0.14–3.2) 0.1 0–2 2 0–8 0.01
Imaging Features
LVEF (%) 55 ±11 56 ±9 48 ±16 <0.05
Vegetation 85 83.3% 71 84.5% 14 77.8% 0.5
Abscess 30 29.4% 21 25% 9 50% 0.03
Fistula 3 2.9% 3 3.6% 0 0% 0.4
Leaflet perforation 26 25.5% 24 28.6% 2 11.1% 0.1
Pseudoaneurysm 10 9.8% 9 10.7% 1 5.6% 0.7
Prosthetic detachment 24 23.5% 15 17.9% 9 50% <0.01

CKD: chronic kidney disease; IT: immunosuppressive treatment; IE: infective endocarditis; IE-aHF: infective endocarditis-related heart failure; S-D: symptoms to diagnosis; WBCC: white blood cell count; CRP: C-reactive protein; PCT: procalcitonin; LVEF: left ventricular ejection fraction.